UNIVERSITY OF MIAMI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 48
- Registration Number
- NCT05366816
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries
Phase 4
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- University of Miami
- Registration Number
- NCT05364099
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 1000
- Registration Number
- NCT05361694
- Locations
- 🇺🇸
University of Miami Hospitals, Miami, Florida, United States
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 75
- Registration Number
- NCT05352061
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
SpeakFree Heat and Moisture Exchanger (HME)
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 36
- Registration Number
- NCT05349487
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 13
- Registration Number
- NCT05327361
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- University of Miami
- Registration Number
- NCT05321953
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 100
- Registration Number
- NCT05319860
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Pain and Hysteroscopy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 70
- Registration Number
- NCT05316506
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 50
- Registration Number
- NCT05296070
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸City of Hope National Medical Center, Duarte, California, United States
© Copyright 2024. All Rights Reserved by MedPath